Trial site
H Lee Moffitt Cancer Center
- 15running trials
- 14closed trials
The trials here
What the 29 trials at this site are about, from their registry records.
- Conditions
- Acute lymphoblastic leukaemia5 trials
- Acute myeloid leukaemia4 trials
- Hodgkin lymphoma4 trials
- Multiple myeloma4 trials
- Prostate cancer4 trials
- Childhood cancers3 trials
- Chronic lymphocytic leukaemia3 trials
- Aplastic anaemia2 trials
- Chronic myeloid leukaemia2 trials
- Colorectal cancer2 trials
- Follicular lymphoma2 trials
- Kidney cancer2 trials
- and 15 more
- Phase
- Phase 28 trials
- Phase 16 trials
- Phase 1/26 trials
- Phase 34 trials
- Status
- Completed12 trials
- Active, not recruiting11 trials
- Recruiting4 trials
- Terminated2 trials
- Lead sponsor
- Regeneron Pharmaceuticals4 trials
- Center for International Blood and Marrow Transplant Research3 trials
- Eli Lilly and Company2 trials
- Janssen Research & Development, LLC2 trials
- Kite, A Gilead Company2 trials
- and 15 more
Running trials
Recruiting
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Recruiting
Active, not recruiting
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
Active, not recruiting
Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
Recruiting
Active, not recruiting
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer
Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Kidney cancer1 recruiting
- Melanoma1 recruiting
Closed trials
Terminated
Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events
Recruiting
Terminated
Completed
Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma
Completed
HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903
Recruiting
Completed
Completed
Completed
Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)
Completed
Completed
Completed
A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma
Completed
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026